Navigation Links
Pharmocogenomics has not fulfilled its promise to developing countries
Date:4/2/2014

From 1997 to 2010, despite promises made by the international scientific community, pharmacogenomic research produced few studies focusing on rare, orphan and tropical diseases prevalent in developing countries. Catherine Olivier, bioethics research at the University of Montreal's School of Public Health, recently published these findings in the journal Global Public Health.

Pharmcogenomics is a field of scientific research that studies the interaction between the genomic information of individuals (or populations) and their responses to drugs. In addition to its promising potential for the emergence of personalized medicine, pharmacogenomics held the potential to contribute to the development and accessibility of treatments for rare and orphan diseases including tropical infections in developing countries.

In general, "it is recognized that the distribution of technology and research follows the so-called 90/10 ratio rule, that is, 90% of global funding for health research, including the development drugs, is invested to treat 10% of the world's population," Olivier explained. This inequality between rich and poor countries had led the United Nations (UN) to make the fight against HIV-AIDS, malaria, and neglected tropical diseases one of its eight Millennium Development Goals, adopted in September 2000 by the 189 UN member states.

More than 600 studies analyzed

To verify the extent to which pharmacogenomics research has addressed rare, orphan, and tropical diseases, Olivier identified the focus of studies published in this area from 1997 to 2010.

As a result, she identified 626 studies published in 171 different journals.

Each study was analyzed according to the type of disease it concerned, the origin of its authors, and the latter's affiliation with pharmaceutical companies, if any. "The information collected allowed us to draw a map showing current and historical trends in the development of pharmacogenomic research,"
'/>"/>

Contact: William Raillant-Clark
w.raillant-clark@umontreal.ca
514-566-3813
University of Montreal
Source:Eurekalert

Page: 1 2

Related biology news :

1. The shape of things to come: NIST probes the promise of nanomanufacturing using DNA origami
2. UofL research holds promise of therapeutic approach for gum disease
3. Innovative cell printing technologies hold promise for tissue engineering R&D
4. Transcatheter aortic valve implantation shows promise in patients with severe aortic stenosis
5. New stem cell technique promises abundance of key heart cells
6. A sea of broken promises
7. New compound holds promise for treating Duchenne MD, other inherited diseases
8. Nanoscale scaffolds and stem cells show promise in cartilage repair
9. New drug shows promise for kidney disease
10. Common antifungal drug decreases tumor growth and shows promise as cancer therapy
11. Silicone foul release coatings show promise to manage invasive mussels at water facilities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/16/2015)... 16, 2015 Between 16 ... present groundbreaking innovations in biometric identification at the ... .      (Photo: http://photos.prnewswire.com/prnh/20150316/735333 ... is well at the forefront: the company,s all ... in Germany . BiometricGate is ...
(Date:3/12/2015)... 12, 2015 Beta Systems ... and access management (IAM) solution for a fixed ... Beta System,s new IAM package, customers benefit from ... from multiple IAM implementations across different industries. The ... well as any necessary services and consulting. It ...
(Date:3/11/2015)... , March 11, 2015   The Sync ... platform to scientifically measure and harness music to ... real-time biometrics and objective measurements of physiology, enabling ... at scale in large populations. It is designed ... and clinicians perform rigorous studies and accelerate the ...
Breaking Biology News(10 mins):DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 2DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 3Beta Systems Fast Forward IAM Available Now: a Standardized IAM Package at a Fixed Price 2Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 2Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 3
... cracked the problem of pod shatter in brassica crops such ... are prone to shatter, causing a 10-25% loss of seeds ... producing a hormone in a specific region of the fruit, ... plant Arabidopsis , completely sealing the seeds inside," says ...
... Paul Anastas, Yale,s Teresa and H. John Heinz III ... to lead the U.S. Environmental Protection Agency,s (EPA,s) Office ... of the Center for Green Chemistry & Green Engineering ... chemical engineering and the School of Forestry & Environmental ...
... alleviate diseases associated with menopause, she didn,t realize her ... hundreds of millions of people. The Northern Arizona ... University of Arizona identified a nontoxic chemical technology that ... feast on crops intended for human consumption. ...
Cached Biology News:Shatter-resistant brassicas 2'Father of green chemistry' Paul Anastas to head EPA research 2NAU discovery could help feed millions 2NAU discovery could help feed millions 3
(Date:3/27/2015)... , March 27, 2015   SurePure, Inc ... photopurification, announced today that the Company has completed ... continued trading of SurePure ("SURP") securities on OTCQB, ... for entrepreneurial and development stage companies. ... standards and eligibility requirements designed to improve marketplace ...
(Date:3/27/2015)... 2015  CASI Pharmaceuticals, Inc. (Nasdaq: CASI ), ... commercialization of innovative therapeutics addressing cancer and other unmet ... focus on China , today reported ... December 31, 2014.  The Company reported ... share, for the three months ended December 31, 2014.  ...
(Date:3/26/2015)... SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: SQD; ... including the appointment of auditors, its annual and special ... "Meeting") was adjourned, as previously disclosed on March 25, ... Toronto time). The date of the ... The Meeting will reconvene at the offices of the ...
(Date:3/26/2015)... March 26, 2015 Neogen Corporation (NASDAQ: ... the third quarter of fiscal 2015, which ended Feb. ... prior year,s $6,575,000. Earnings per share in the current ... Current year-to-date net income increased 17% over prior year ... or $0.56 per share, for the same period a ...
Breaking Biology Technology:SurePure Completes Verification and Approved for Trading on the OTCQB Marketplace 2CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 2CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 3CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 4CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 5CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 6SQI Diagnostics Inc. Announces Adjournment of Meeting 2Neogen reports 13% increase in net income 2Neogen reports 13% increase in net income 3Neogen reports 13% increase in net income 4Neogen reports 13% increase in net income 5Neogen reports 13% increase in net income 6Neogen reports 13% increase in net income 7Neogen reports 13% increase in net income 8
... Corporation (NYSE: SHP ) ("ShangPharma" or ... research and development outsourcing company, today announced that ... Commerce as one of the Top Ten Leading ... top ten companies were announced at the Fourth ...
... development of the first self-powered nano-device that can transmit ... ACS,s journal Nano Letters , they say it ... implantable medical sensors, airborne and stationary surveillance cameras and ... independently without batteries on energy collected from the environment. ...
... June 15, 2011 Solid grounding in science is ... of American leaders. From biochemists and pharmacists to physician ... States job market lies in the fields of healthcare ... online survey conducted by Harris Interactive for University ...
Cached Biology Technology:ShangPharma Corporation Named a Top Ten Chinese Outsourcing Enterprise 2Careers in Healthcare and Science? "Not Interested" Say Half of U.S. Teens 2Careers in Healthcare and Science? "Not Interested" Say Half of U.S. Teens 3Careers in Healthcare and Science? "Not Interested" Say Half of U.S. Teens 4
The AVR9-8 stream-select valve is a 9-port, 8-position valve for use with the BioLogic DuoFlow system. This valve is used for high-pressure stream selection....
... BioGenex Super Sensitive MultiLink IHC ... species-specific secondary antibodies, labeled with ... to the bound primary antibody, ... a Streptavidin-Enzyme conjugate. This kit ...
Sf21 Insect Cells (Live) in Max-XP Medium...
EZ-DeWax is a one-step solution that simultanously removes paraffin from and rehydrates formalin-fixed, paraffin embedded tissue...
Biology Products: